Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of $201.21 billion. The enterprise value is $218.15 billion.
| Market Cap | 201.21B |
| Enterprise Value | 218.15B |
Important Dates
The next estimated earnings date is Tuesday, July 16, 2024, before market open.
| Earnings Date | Jul 16, 2024 |
| Ex-Dividend Date | Mar 7, 2024 |
Share Statistics
Novartis AG has 1.96 billion shares outstanding.
| Shares Outstanding | 1.96B |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 6.91% |
| Float | 1.95B |
Valuation Ratios
The trailing PE ratio is 23.31 and the forward PE ratio is 13.25. Novartis AG's PEG ratio is 5.09.
| PE Ratio | 23.31 |
| Forward PE | 13.25 |
| PS Ratio | 4.02 |
| Forward PS | 4.00 |
| PB Ratio | 5.06 |
| P/FCF Ratio | 15.52 |
| PEG Ratio | 5.09 |
Enterprise Valuation
| EV / Earnings | 14.31 |
| EV / Sales | 4.37 |
| EV / EBITDA | n/a |
| EV / EBIT | 12.99 |
| EV / FCF | 16.88 |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.69.
| Current Ratio | 0.90 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.11 |
| Interest Coverage | 19.00 |
Financial Efficiency
Return on equity (ROE) is 34.60% and return on invested capital (ROIC) is 15.22%.
| Return on Equity (ROE) | 34.60% |
| Return on Assets (ROA) | 14.60% |
| Return on Capital (ROIC) | 15.22% |
| Revenue Per Employee | $656,402 |
| Profits Per Employee | $200,442 |
| Employee Count | 76,057 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, Novartis AG has paid $671.00 million in taxes.
| Income Tax | 671.00M |
| Effective Tax Rate | 4.22% |
Stock Price Statistics
The stock price has increased by +2.09% in the last 52 weeks. The beta is 0.47, so Novartis AG's price volatility has been lower than the market average.
| Beta (1Y) | 0.47 |
| 52-Week Price Change | +2.09% |
| 50-Day Moving Average | 97.35 |
| 200-Day Moving Average | 99.55 |
| Relative Strength Index (RSI) | 69.93 |
| Average Volume (30 Days) | 1,595,961 |
Short Selling Information
| Short Interest | 4.22M |
| Short Previous Month | 4.21M |
| Short % of Shares Out | 0.26% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.21 |
Income Statement
In the last 12 months, Novartis AG had revenue of $49.92 billion and earned $15.25 billion in profits. Earnings per share was $7.38.
| Revenue | 49.92B |
| Gross Profit | 36.35B |
| Operating Income | 10.64B |
| Pretax Income | 15.92B |
| Net Income | 15.25B |
| EBITDA | n/a |
| EBIT | 16.80B |
| Earnings Per Share (EPS) | $7.38 |
Balance Sheet
The company has $9.69 billion in cash and $27.28 billion in debt, giving a net cash position of -$17.59 billion or -$8.99 per share.
| Cash & Cash Equivalents | 9.69B |
| Total Debt | 27.28B |
| Net Cash | -17.59B |
| Net Cash Per Share | -$8.99 |
| Equity / Book Value | 39.68B |
| Book Value Per Share | 20.28 |
| Working Capital | -2.84B |
Cash Flow
In the last 12 months, operating cash flow was $13.77 billion and capital expenditures -$844.00 million, giving a free cash flow of $12.92 billion.
| Operating Cash Flow | 13.77B |
| Capital Expenditures | -844.00M |
| Free Cash Flow | 12.92B |
| FCF Per Share | $6.32 |
Margins
Gross margin is 72.81%, with operating and profit margins of 21.31% and 30.54%.
| Gross Margin | 72.81% |
| Operating Margin | 21.31% |
| Pretax Margin | 31.88% |
| Profit Margin | 30.54% |
| EBITDA Margin | n/a |
| EBIT Margin | 33.65% |
| FCF Margin | 25.88% |
Dividends & Yields
This stock pays an annual dividend of $3.78, which amounts to a dividend yield of 3.67%.
| Dividend Per Share | $3.78 |
| Dividend Yield | 3.67% |
| Dividend Growth (YoY) | 8.88% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 51.18% |
| Buyback Yield | 3.02% |
| Shareholder Yield | 6.70% |
| Earnings Yield | 7.60% |
| FCF Yield | 6.44% |
Analyst Forecast
The average price target for Novartis AG is $115.00, which is 11.82% higher than the current price. The consensus rating is "Hold".
| Price Target | $115.00 |
| Price Target Difference | 11.82% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 3.01% |
| EPS Growth Forecast (5Y) | 5.77% |
Stock Splits
The last stock split was on April 9, 2019. It was a forward split with a ratio of 1116:1000.
| Last Split Date | Apr 9, 2019 |
| Split Type | Forward |
| Split Ratio | 1116:1000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |